474 related articles for article (PubMed ID: 33092220)
41. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
42. Acute Neurotoxicity Models of Prion Disease.
T Islam AM; Adlard PA; Finkelstein DI; Lewis V; Biggi S; Biasini E; Collins SJ
ACS Chem Neurosci; 2018 Mar; 9(3):431-445. PubMed ID: 29393619
[TBL] [Abstract][Full Text] [Related]
43. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
Iraci N; Stincardini C; Barreca ML; Biasini E
Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
[TBL] [Abstract][Full Text] [Related]
44. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
45. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
46. Physiological and pathological functions of the prion protein homologue Dpl.
Behrens A
Br Med Bull; 2003; 66():35-42. PubMed ID: 14522847
[TBL] [Abstract][Full Text] [Related]
47. The cellular prion protein (PrP(C)): its physiological function and role in disease.
Westergard L; Christensen HM; Harris DA
Biochim Biophys Acta; 2007 Jun; 1772(6):629-44. PubMed ID: 17451912
[TBL] [Abstract][Full Text] [Related]
48. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of prion-induced neurodegeneration.
Saá P; Harris DA; Cervenakova L
Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
[TBL] [Abstract][Full Text] [Related]
50. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
51. Diminished Neuronal ESCRT-0 Function Exacerbates AMPA Receptor Derangement and Accelerates Prion-Induced Neurodegeneration.
Lawrence JA; Aguilar-Calvo P; Ojeda-Juárez D; Khuu H; Soldau K; Pizzo DP; Wang J; Malik A; Shay TF; Sullivan EE; Aulston B; Song SM; Callender JA; Sanchez H; Geschwind MD; Roy S; Rissman RA; Trejo J; Tanaka N; Wu C; Chen X; Patrick GN; Sigurdson CJ
J Neurosci; 2023 May; 43(21):3970-3984. PubMed ID: 37019623
[TBL] [Abstract][Full Text] [Related]
52. Microglial cells in neurodegenerative disorders.
Wojtera M; Sikorska B; Sobow T; Liberski PP
Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
[TBL] [Abstract][Full Text] [Related]
53. Retrograde transport of transmissible mink encephalopathy within descending motor tracts.
Bartz JC; Kincaid AE; Bessen RA
J Virol; 2002 Jun; 76(11):5759-68. PubMed ID: 11992004
[TBL] [Abstract][Full Text] [Related]
54. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
Benvegnù S; Poggiolini I; Legname G
J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
[TBL] [Abstract][Full Text] [Related]
55. Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
Otero A; Betancor M; Eraña H; Fernández Borges N; Lucas JJ; Badiola JJ; Castilla J; Bolea R
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466523
[TBL] [Abstract][Full Text] [Related]
56. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
57. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
58. A New Take on Prion Protein Dynamics in Cellular Trafficking.
Alves RN; Iglesia RP; Prado MB; Melo Escobar MI; Boccacino JM; Fernandes CFL; Coelho BP; Fortes AC; Lopes MH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092231
[TBL] [Abstract][Full Text] [Related]
59. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.
Watts JC; Drisaldi B; Ng V; Yang J; Strome B; Horne P; Sy MS; Yoong L; Young R; Mastrangelo P; Bergeron C; Fraser PE; Carlson GA; Mount HT; Schmitt-Ulms G; Westaway D
EMBO J; 2007 Sep; 26(17):4038-50. PubMed ID: 17703189
[TBL] [Abstract][Full Text] [Related]
60. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
